NVCT R&D Expenses
Nuvectis Pharma Inc · R&D Expenses
NVCT R&D Expenses
Latest reported$19.65Mperiod ending
NVCT TTM R&D Expenses ($9.55M → $19.65M)
TTM R&D Expenses
High-resolution chart · PNG
NVCT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 19,650,000 | |
| 18,579,000 | |
| 18,153,000 | |
| 17,563,000 | |
| 14,608,000 | |
| 13,938,000 | |
| 12,918,000 | |
| 12,687,000 | |
| 14,354,000 | |
| 15,673,000 | |
| 15,380,000 | |
| 15,512,000 | |
| 15,546,000 | |
| 13,789,000 | |
| 13,227,000 | |
| 9,974,000 | |
| 9,610,000 | |
| 11,350,000 | |
| 9,545,000 |